Hundreds of EpiPen users complained about problems with the lifesaving device. It still took 3 years and a top regulator stepping in before serious change — with potentially deadly outcomes

Comments

Post a Comment

Popular posts from this blog

Trump proposes new immigration plan favouring skills over family

US President Donald Trump has said he wants to overhaul the immigration system to favour young, educated, English-speaking applicants with job offers instead of people with family ties to Americans. Setting aside some of his hardline rhetoric on irregular immigration, Trump said on Thursday that he wants to recruit “top talent” to the nation as he unveiled his latest efforts to reform residency laws after years of setbacks and stalemates. Trump’s plan, roundly panned by Democrats and immigration advocacy groups, is aimed at trying to unite Republicans – some who want to boost immigration, others who want to restrict it – ahead of the November 2020 presidential and congressional elections. “We discriminate against genius,” Trump said of current policies, which he contended excessively favour family-based immigration. “We won’t any more once we get this passed,” Trump said in a Rose Garden address to Republican lawmakers and Cabinet members. Currently, about two-thirds of the 1.1...
Read more

The Trump administration just proposed a ban on a little-known practice in the pharmaceutical industry that’s been blamed for high drug prices

The Trump administration just made a big move against a little-known pricing practice that the pharmaceutical supply chain depends on. On Thursday, the Department of Health and Human Services (HHS) said it’s proposing a rule that would effectively ban the use of rebates for pharmaceutical drugs. HHS said the move is designed to lower the cost of prescription drugs for patients, a major goal for the administration. “This proposal has the potential to be the most significant change in how Americans’ drugs are priced at the pharmacy counter, ever, and finally ease the burden of the sticker shock that millions of Americans experience every month for the drugs they need,” HHS Secretary Alex Azar said in a statement. Drugmakers pay out more than $100 billion in rebates annually. Rebates are a big business for pharmaceutical middlemen, otherwise known as pharmacy benefit managers (PBMs), such as Express Scripts, CVS Caremark, and OptumRx. Cigna, which owns Express Scripts, and CVS Health...
Read more